Human Genome Epidemiology Literature Finder
Records 1 - 29 (of 29 Records) |
Query Trace: Tuberculosis and SLCO1B1[original query] |
---|
Effects of tuberculosis, race, and human gene SLCO1B1 polymorphisms on rifampin concentrations. Antimicrobial agents and chemotherapy 2010 Oct 54 (10): 4192-200. Weiner Marc, Peloquin Charles, Burman William, Luo Chi-Cheng, Engle Melissa, Prihoda Thomas J, Mac Kenzie William R, Bliven-Sizemore Erin, Johnson John L, Vernon Andr |
The SLCO1B1 rs4149032 polymorphism is highly prevalent in South Africans and is associated with reduced rifampin concentrations: dosing implications. Antimicrobial agents and chemotherapy 2011 Jun . Chigutsa E, Visser ME, Swart EC, Denti P, Pushpakom S, Egan D, Holford NH, Smith PJ, Maartens G, Owen A, McIlleron H |
Polymorphisms in drug transporter genes (ABCB1, SLCO1B1 and ABCC2) and hepatitis induced by antituberculosis drugs. Tuberculosis (Edinburgh, Scotland) 2012 Jan 92 (1): 100-4. Kim Sang-Hoon, Kim Sang-Heon, Lee Jae-Hyung, Lee Byoung-Hoon, Kim Youn-Seup, Park Jae-Seuk, Jee Young-K |
Low rifampicin concentrations in tuberculosis patients with HIV infection. Journal of infection in developing countries 2014 Aug 8 (8): 987-93. Gengiah Tanuja Narayansamy, Botha Julia Hillary, Soowamber Deepak, Naidoo Kogieleum, Abdool Karim Salim |
Association of genetic variants with anti-tuberculosis drug induced hepatotoxicity: a high resolution melting analysis. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2014 Apr 23 42-8. Singh Meenakshi, Gupta Vinod H, Amarapurkar Deepak N, Joshi Jyotsna M, Baijal Rajiv, Ramegowda Praveenkumar H, Amarapurkar Anjali D, Wangikar Pramod |
Association of polymorphisms in drug transporter genes (SLCO1B1 and SLC10A1) and anti-tuberculosis drug-induced hepatotoxicity in a Chinese cohort. Tuberculosis (Edinburgh, Scotland) 2015 Jan 95 (1): 68-74. Chen Ru, Wang Jing, Tang Shaowen, Zhang Yuan, Lv Xiaozhen, Wu Shanshan, Xia Yinyin, Deng Peiyuan, Ma Yu, Tu Dehua, Chen Dafang, Zhan Siy |
Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis. Antimicrobial agents and chemotherapy 2015 Oct . Hennig Stefanie, Naiker Suhashni, Reddy Tarylee, Egan Deirdre, Kellerman Tracy, Wiesner Lubbe, Owen Andrew, McIlleron Helen, Pym Alexand |
SLCO1B1 gene polymorphisms do not influence plasma rifampicin concentrations in a South Indian population. The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 2016 09 20 (9): 1231-5. Ramesh K, Hemanth Kumar A K, Kannan T, Vijayalakshmi R, Sudha V, Manohar Nesakumar S, Bharathiraja T, Lavanya J, Swaminathan S, Ramachandran |
[Study on polymorphisms of genes with susceptibility to drug induced liver injury in a cohort receiving anti-tuberculosis treatment]. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi 2016 Jul 37 (7): 925-9. Chen R, Wang J, Tang S W, Lyu X Z, Zhang Y, Wu S S, Xia Y Y, Zhan S |
Genetic Polymorphisms of SLCO1B1, CYP2E1 and UGT1A1 and Susceptibility to Anti-Tuberculosis Drug-Induced Hepatotoxicity: A Chinese Population-Based Prospective Case-Control Study. Clinical drug investigation 2017 Sep . Sun Qin, Liu Hai-Peng, Zheng Rui-Juan, Wang Peng, Liu Zhi-Bin, Sha Wei, Xiao He-Pi |
Effect of Genetic Variation of NAT2 on Isoniazid and SLCO1B1 and CES2 on Rifampin Pharmacokinetics in Ghanaian Children with Tuberculosis. Antimicrobial agents and chemotherapy 2017 Dec . Dompreh Albert, Tang Xiaoli, Zhou Jianlin, Yang Hongmei, Topletz Ariel, Adu Ahwireng Eugene, Antwi Sampson, Enimil Antony, Langaee Taimour, Peloquin Charles A, Court Michael H, Kwara Awewu |
Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin. European journal of clinical pharmacology 2018 7 74 (11): 1405-1415. Mugusi Sabina, Ngaimisi Eliford, Janabi Mohammed, Mugusi Ferdinand, Minzi Omary, Aris Eric, Bakari Muhammad, Bertilsson Leif, Burhenne Juergen, Sandstrom Eric, Aklillu Ele |
Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis. Antimicrobial agents and chemotherapy 2018 Feb . Weiner Marc, Gelfond Jon, Johnson-Pais Teresa L, Engle Melissa, Peloquin Charles A, Johnson John L, Sizemore Erin E, Mac Kenzie William |
Association of genetic polymorphisms of CYP2E1, NAT2, GST and SLCO1B1 with the risk of anti-tuberculosis drug-induced liver injury: a systematic review and meta-analysis. BMJ open 2019 Aug 9 (8): e027940. Yang Seungwon, Hwang Se Jung, Park Jung Yun, Chung Eun Kyoung, Lee Jangik |
The Influence of Pharmacogenetic Variants in HIV/Tuberculosis Coinfected Patients in Uganda in the SOUTH Study. Clinical pharmacology and therapeutics 2019 Feb . Calcagno Andrea, Cusato Jessica, Sekaggya-Wiltshire Christine, von Braun Amrei, Motta Ilaria, Turyasingura Grace, Castelnuovo Barbara, Fehr Jan, Di Perri Giovanni, Lamorde Mohamm |
Effects of genetic variability on rifampicin and isoniazid pharmacokinetics in South African patients with recurrent tuberculosis. Pharmacogenomics 2019 Feb . Naidoo Anushka, Chirehwa Maxwell, Ramsuran Veron, McIlleron Helen, Naidoo Kogieleum, Yende-Zuma Nonhlanhla, Singh Ravesh, Ncgapu Sinaye, Adamson John, Govender Katya, Denti Paolo, Padayatchi Nes |
Role of pharmacogenetics in rifampicin pharmacokinetics and the potential effect on TB-rifampicin sensitivity among Ugandan patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 2019 Dec . Mukonzo Jackson K, Kengo Allan, Kutesa Bisaso, Nanzigu Sarah, Pohanka Anton, McHugh Timothy D, Zumla Alimuddin, Aklillu Ele |
A population approach of rifampicin pharmacogenetics and pharmacokinetics in Mexican patients with tuberculosis. Tuberculosis (Edinburgh, Scotland) 2020 Aug 124 101982. Medellin-Garibay Susanna Edith, Huerta-García Ana Patricia, Rodríguez-Báez Ana Socorro, Magaña-Aquino Martín, Ortiz-Álvarez Arturo, Portales-Pérez Diana Patricia, Milán-Segovia Rosa Del Carmen, Romano-Moreno Silv |
Influence of Single Nucleotide Polymorphisms on Rifampin Pharmacokinetics in Tuberculosis Patients. Antibiotics (Basel, Switzerland) 2020 6 9 (6): . Thomas Levin, Sekhar Miraj Sonal, Surulivelrajan Mallayasamy, Varma Muralidhar, Sanju Chidananda S V, Rao Mahad |
Genetic Diversity in Drug Transporters: Impact in African Populations. Clinical and translational science 2020 2 13 (5): 848-860. Rajman Iris, Knapp Laura, Hanna Im |
Decreased plasma rifapentine concentrations associated with AADAC single nucleotide polymorphism in adults with tuberculosis. The Journal of antimicrobial chemotherapy 2020 Dec . Weiner Marc, Gelfond Jon, Johnson-Pais Teresa L, Engle Melissa, Johnson John L, Whitworth William C, Bliven-Sizemore Erin, Nsubuga Pheona, Dorman Susan E, Savic Rada, |
Relationship among genetic polymorphism of SLCO1B1, rifampicin exposure and clinical outcomes in patients with active pulmonary tuberculosis. British journal of clinical pharmacology 2021 Feb . Kim Eun Sun, Kwon Byoung Soo, Park Jong Sun, Chung Jae-Yong, Seo Soo Hyun, Park Kyoung Un, Song Junghan, Yoon Seonghae, Lee Jae |
SLCO1B1 and SLC10A1 polymorphism and plasma rifampin concentrations in patients with co-morbidity tuberculosis-diabetes mellitus in Baja California, Mexico. Tuberculosis (Edinburgh, Scotland) 2022 Sep 136 102248. Perea-Jacobo Ricardo, Muñiz-Salazar Raquel, Laniado-Laborín Rafael, Zenteno-Cuevas Roberto, Cabello-Pasini Alejandro, Ochoa-Terán Adrián, Radilla-Chávez Patric |
Effect of Genetic Variations in Drug-Metabolizing Enzymes and Drug Transporters on the Pharmacokinetics of Rifamycins: A Systematic Review. Pharmacogenomics and personalized medicine 2022 15 561-571. Sileshi Tesemma, Mekonen Gosaye, Makonnen Eyasu, Aklillu Ele |
Pharmacogenetics of tuberculosis treatment toxicity and effectiveness in a large Brazilian cohort. medRxiv : the preprint server for health sciences 2023 9 . Gustavo Amorim, James Jaworski, Marcelo Cordeiro-Santos, Afrânio L Kritski, Marina C Figueiredo, Megan Turner, Bruno B Andrade, Digna R Velez Edwards, Adalberto R Santos, Valeria C Rolla, Timothy R Sterling, David W Haas, |
SLCO1B1 Polymorphisms are Associated with the Susceptibility to Pulmonary Tuberculosis in Chinese Females. Biochemical genetics 2023 6 . Wei Li, Wei Liu, Xiong Wang, Rui Dou, Zunmin Z |
Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database. BMC pulmonary medicine 2023 11 23 (1): 471. Woo Jung Seo, Hyeon-Kyoung Koo, Ji Yeon Kang, Jieun Kang, So Hee Park, Hyung Koo Kang, Hye Kyeong Park, Sung-Soon Lee, Sangbong Choi, Tae Won Jang, Kyeong-Cheol Shin, Jee Youn Oh, Joon Young Choi, Jinsoo Min, Young-Kyung Choi, Jae-Gook Shin, Yong-Soon C |
Population Pharmacokinetic Model of Rifampicin for Personalized Tuberculosis Pharmacotherapy: Effects of SLCO1B1 Polymorphisms on Drug Exposure. International journal of antimicrobial agents 2023 11 107034. Pham Quang Hoa, Kim Hyun Kuk, Tae Won Jang, Hyewon Seo, Jee Youn Oh, Ho Cheol Kim, Ah Young Shin, Jinsoo Min, Rannissa Puspita Jayanti, Tran Minh Hung, Nguyen Ky Anh, Sangzin Ahn, Nguyen Phuoc Long, Yong-Soon Cho, Jae-Gook Shin, |
Polymorphisms of SLCO1B1 Gene in Sundanese Ethnic Population of Tuberculosis Patients in Indonesia. Acta medica Indonesiana 2023 1 54 (4): 517-523. Santoso Prayudi, Juliastuti Henny, Nataprawira Heda Melinda, Soeroto Arto Yuwono, Alisjahbana Bachti, Ruslami Rovina, Debora Josephine, Sribudiani Yunia, Maskoen Ani Mela |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: